Literature DB >> 2469080

Metabolite formation pharmacokinetics: rate and extent of metabolite formation determined by deconvolution.

M D Karol1, S Goodrich.   

Abstract

A two-step analytic procedure to determine the rate and extent of metabolite production following administration of the parent compound is described. The procedure provides the rate and extent of metabolite production as a function of time by application of the general model independent approach of deconvolution. The metabolite unit impulse response function is obtained by implicit deconvolution of the metabolite data with a truncated constant-rate metabolite input function. Then the obtained unit impulse response function is used in an analytic deconvolution with metabolite data following administration of the parent compound to obtain the rate and extent of metabolite production. The input function is also deconvolved with metabolite data to obtain the unit impulse response function appropriate for prediction of metabolite levels given a selected input of parent compound. The expected profile following administration of the consecutive infusions of parent drug is shown for both parent and metabolite. The rationale for selection of deconvolution methods is discussed. The approach is applied to data for procainamide and N-acetylprocainamide from three human subjects. The results indicate that from 27 to 39% of the procainamide was converted to N-acetylprocainamide in these subjects.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2469080     DOI: 10.1023/a:1015951426191

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  13 in total

1.  Procainamide and N-acetylprocainamide kinetics investigated simultaneously with stable isotope methodology.

Authors:  J S Dutcher; J M Strong; S V Lucas; W K Lee; A J Atkinson
Journal:  Clin Pharmacol Ther       Date:  1977-10       Impact factor: 6.875

2.  Curve fitting and modeling in pharmacokinetics and some practical experiences with NONLIN and a new program FUNFIT.

Authors:  P V Pedersen
Journal:  J Pharmacokinet Biopharm       Date:  1977-10

3.  Gastrointestinal bioavailability: determination of in vivo release profiles of solid oral dosage forms by deconvolution.

Authors:  W R Gillespie; P Veng-Pedersen
Journal:  Biopharm Drug Dispos       Date:  1985 Jul-Sep       Impact factor: 1.627

Review 4.  A review of metabolite kinetics.

Authors:  K S Pang
Journal:  J Pharmacokinet Biopharm       Date:  1985-12

5.  Numerical deconvolution by least squares: use of prescribed input functions.

Authors:  D J Cutler
Journal:  J Pharmacokinet Biopharm       Date:  1978-06

6.  Mathematical basis of point-area deconvolution method for determining in vivo input functions.

Authors:  D P Vaughan; M Dennis
Journal:  J Pharm Sci       Date:  1978-05       Impact factor: 3.534

7.  An algorithm and computer program for deconvolution in linear pharmacokinetics.

Authors:  P Veng-Pedersen
Journal:  J Pharmacokinet Biopharm       Date:  1980-10

8.  Pharmacokinetic analysis by linear system approach I: cimetidine bioavailability and second peak phenomenon.

Authors:  P Veng Pedersen
Journal:  J Pharm Sci       Date:  1981-01       Impact factor: 3.534

9.  Correlation of the electrophysiological and antiarrhythmic properties of the N-acetyl metabolite of procainamide with plasma and tissue drug concentrations in the dog.

Authors:  E E Bagwell; T Walle; D E Drayer; M M Reidenbert; J K Pruett
Journal:  J Pharmacol Exp Ther       Date:  1976-04       Impact factor: 4.030

10.  Antiarrhythmic potency of procainamide and N-acetylprocainamide in rabbits.

Authors:  R F Minchin; K F Ilett; J W Paterson
Journal:  Eur J Pharmacol       Date:  1978-01-01       Impact factor: 4.432

View more
  2 in total

1.  The pharmacokinetics of trilostane and ketotrilostane in an interconverting system in the rat.

Authors:  J P McGee; P N Shaw
Journal:  Pharm Res       Date:  1992-04       Impact factor: 4.200

2.  Pharmacokinetics and bioinversion of ibuprofen enantiomers in humans.

Authors:  H Cheng; J D Rogers; J L Demetriades; S D Holland; J R Seibold; E Depuy
Journal:  Pharm Res       Date:  1994-06       Impact factor: 4.200

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.